Autor: |
González-Quijano, Génesis K., León-Reyes, Guadalupe, Rosado, Eliane Lopes, Martínez, J. Alfredo, de Luis, Daniel A., Ramos-Lopez, Omar, Tejero, María Elizabeth |
Předmět: |
|
Zdroj: |
Healthcare (2227-9032); Nov2024, Vol. 12 Issue 22, p2292, 29p |
Abstrakt: |
Background/Objectives: Nutrigenetics investigates the role of genetic variants that contribute to the inter-individual variation in response to food intake. Risk factors for cardiovascular disease (CVD) are influenced by the complex interplay of genetic and environmental factors, including the diet. The aim of this scoping review is to analyze the literature on the effect of genotypes on the response to dietary interventions for the treatment of CVD risk factors. Methods: A literature search was conducted in MEDLINE to identify published articles fulfilling the inclusion criteria. Studies published in English between 2014 and 2024 were selected. Data were extracted according to the population, intervention, comparison, and outcome (PICO) format. Results: Forty-eight studies met the inclusion criteria. The studies differed in design, intervention characteristics, tested genotypes, and ancestry. The most frequently analyzed variants were single-nucleotide polymorphisms (SNPs) in genes associated with lipid metabolism, inflammation, and energy balance, among others. The interventions tested the effects of different dietary patterns, diets modified in macronutrient content and types of fat, natural and processed foods, nutraceuticals, and nutrient supplements. Common APOE variants were the most analyzed genotypes showing significant interactions with different dietary interventions affecting blood lipids. Other genotypes found in pathways involving folic acid, lipid metabolism and transport have shown interactions with diverse dietary components across studies. Conclusions: Gene–diet interactions are observed in multiple dietary interventions. Replication of findings of nutrigenetic studies is required across different populations. The response to dietary treatments modifies CVD-related risk factors and shows variation associated with genotypes. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|